Remon R. Rofaeil
Al Minya, MN 61519, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Correction: Sacubitril/valsartan attenuates renal injury caused by cecal ligation and puncture via TLR4/NFκB/NLRP3 inhibition and reduced oxidative stress and apoptosis in rats.
Journal: Scientific reports
Published: September 03, 2026
Deciphering Gentamicin-Induced Nephrotoxicity and Hepatotoxicity: Pathophysiological Insights and Emerging Protective Approaches.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: June 12, 2026
Sacubitril/valsartan attenuates renal injury caused by cecal ligation and puncture via TLR4/NFκB/NLRP3 inhibition and reduced oxidative stress and apoptosis in rats.
Journal: Scientific reports
Published: May 21, 2026
Ulcerative colitis: from molecular pathophysiology to management and the emerging role of natural and pharmacological drug candidates.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 07, 2026
Integrated in vivo and in silico validation of Corchorus olitorius seed-mediated cardioprotection against doxorubicin-induced cardiotoxicity via network pharmacology, molecular docking, and molecular dynamics.
Journal: Frontiers in chemistry
Published: February 13, 2026
Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4/NF-κB and Bax/Bcl-2/caspase-3 signaling cascades: a study based on molecular docking and experimental validation.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 13, 2026
Apremilast attenuates methotrexate-induced hepatic injury in rats; insights into TLR4/NF-κB/P38 MAPK/caspase-3 and α-klotho/Nrf2/HO-1 signaling network interplay.
Journal: Toxicology and applied pharmacology
Published: September 03, 2025
Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 02, 2025
Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathways.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 13, 2025
Unraveling chemotherapy-evoked hepatic dysfunction: a deep dive into cyclophosphamide-related liver injury.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 12, 2025
Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: June 08, 2025
Modulating platelet-activating factor by rupatadine attenuates gentamicin-induced nephrotoxicity in rats via NF-κB/caspase-3 and Nrf2/HO-1 signaling cascades.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 21, 2025
Last Updated: 09/26/2026